journal of cancerfrontiers in oncology

  • PDF Contribution of Vitamin C in the Treatment of

    28. Jain AK Barton MC Bromodomain histone readers and cancer. Journal of Molecular Biology 429 2003 2010. 29. Cha J Roomi MW Ivanov V et al. Ascorbate supplementation inhibits growth and metastasis of B16FO melanoma and 4T1 breast cancer cells in vitamin C deficient mice. International journal of oncology 42 55 64. 30.

  • Format My Manuscript Journal of Clinical Oncology

    Journal article with one two or three authors. 1. Dolan ME Pegg AE O6 Benzylguanine and its role in chemotherapy. Clin Cancer Res 8 1997. Journal article with more than three authors. 2. Knox S Hoppe RT Maloney D et al Treatment of cutaneous T cell lymphoma with chimeric anti CD4 monoclonal antibody. Blood 87 1996

  • Frontiers in OncologySCImago Journal Rank

    Frontiers in Oncology publishes rigorously peer reviewed research across the entire field of cancer research. Field Chief Editor Giuseppe Giaccone at Georgetown University is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open access journal is at the forefront of disseminating and communicating

  • Journal impact Frontiers in OncologyScience research

    Jul 06 2018  Receiving its first Impact Factor this year Frontiers in Oncology ranks in the top Impact Factor and CiteScore percentiles Frontiers in Oncology ranks among the world’s top oncology journals in terms of influence and quality as shown by our analysis of the 2017 Journal Citation Reports JCR 2017 2018 Clarivate Analytics 2017 CiteScore edition 2018 Scopus Elsevier and other impact

  • Jeevin Shahi MDSaint Louis University School of Medicine

    Dr. Jeevin Shahi is a radiation oncologist offering expertise in stereotactic body radiation therapy SBRT and stereotactic radiosurgery SRS . He treats patients with gastrointestinal cancers genitourinary cancers lung cancer and metastatic cancers. His research interests include SBRT for lung liver pancreatic prostate and kidney tumors.

  • Frontiers in Oncology Acceptance Rate Rejection Rate

    The definition of journal acceptance rate is the percentage of all articles submitted to Frontiers in Oncology that was accepted for publication. Based on the Journal Acceptance Rate Feedback System database the latest acceptance rate of Frontiers in Oncology is 50.0 .

  • Frontiers in Oncology Women s Cancer

    Women’s Cancer is a specialty section of Oncology dedicated to advancing scientific and clinical knowledge of breast and gynecologic cancers. This section seeks to publish articles addressing novel findings controversies and innovative hypotheses in the

  • ICG‐fluorescence imaging for detection of peritoneal

    Aug 08 2017  Catalin‐Florin Pop Isabelle Veys Maria Gomez Galdon Michel Moreau Denis Larsimont Vincent Donckier Pierre Bourgeois Gabriel Liberale Ex vivo indocyanine green fluorescence imaging for the detection of lymph node involvement in advanced‐stage ovarian cancer Journal of Surgical Oncology 10.1002/jso.25263 118 7 2018 .

  • Frontiers in oncology Abbreviation ISSNJournal

    Previous Journal Reports of practical oncology and radiotherapy Abbreviation Next Journal Recherches geographiques a Strasbourg Abbreviation Similar Journals

  • Journal Rankings on Oncology

    Ca A Cancer Journal for Clinicians. journal. 62.937 Q1. 168 47 119. 3452. 15499 80 126.34. 73.45.

  • Dangling Accelerated Approvals in Oncology NEJM

    Apr 21 2021  Dangling Accelerated Approvals in Oncology The FDA recently reevaluated accelerated approvals for 35 oncology indications for anti–programmed death ligand 1 antibodies revealing that for

  • DeWyngaert J. K

    International journal of radiation oncology biology physics. 2015 Academic Article GET IT Times cited 13 Use of a Flexible Inflatable Multi Channel Applicator for Vaginal Brachytherapy in the Management of Gynecologic Cancer. Frontiers in oncology. 2015 Academic Article GET IT Times cited 3 Point/Counterpoint. Proton therapy is the most

  • Therapeutic Advances in Medical Oncology SAGE Journals

    Jul 23 2021  About this journal. Therapeutic Advances in Medical Oncology TAM is a peer reviewed open access journal which focuses on pioneering efforts and innovative studies in the medical treatment of cancer. The journal is a member of the Committee on Publication Ethics COPE . More. Find out more about our open Special Collections and submit your

  • New Frontiers in Mucositis American Society of Clinical

    DOI 10.14694/EdBook AM.2012.32.46 American Society of Clinical Oncology Educational Bookpublished online before print May 17 2012 . PMID

  • The Role of PET/CT Imaging in Lung Cancer

    Oncology Letters 3 . Chi A. and Nguyen N.P. 2014 The Utility of Positron Emission Tomography in the Treatment Planning of Image Guided Radiotherapy for Non Small Cell Lung Cancer. Frontiers in Oncology 4 Article No. 273.

  • Frontiers in OncologyPeeref

    Note The following journal information is for reference only. Please check the journal website for updated information prior to submission. MedicineOncology #174/340 MedicineCancer Research #141/207 H index. 60

  • Experimental cancer immunology and therapy LUMC

    They are represented in the editorial boards of key journals dedicated to this research subject e.g. J. Translational Medicine Cancer Immunology Immunotherapy Cancer Immunology Research OncoImmunology Journal for ImmunoTherapy of Cancer Frontiers in Immunology and Oncology .

  • Cancer Journals CancerIndex

    X. 7475. American Society of Clinical Oncology. Journal of the National Cancer Institute. . 5300. Oxford University Press. Cancer and Metastasis Reviews. .

  • Frontiers in OncologyDOAJ

    Aug 14 2012  A peer reviewed open access journal in cancer research clinical oncology cancer genetics molecular targets surgical oncology. DOAJ is a community curated online directory that indexes and provides access to high quality open access peer reviewed journals.

  • Journal of OncologyHindawi

    Jan 05 2021  Objectives . Immune checkpoint inhibitors ICI combined with radiotherapy RT have emerged as a breakthrough therapy in the treatment of various cancers. The combination has a strong rationale but data on their efficacy and safety are still limited. Hence we comprehensively searched the database and performed this study to elucidate the clinical manifestations of this combined strategy.

  • Therapeutic Effects of Curcumin Against Colorectal Cancer

    Oct 08 2020  Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF κB and Src protein kinase signaling pathways. PLoS One 8 2 e57218–e57218. Google Scholar. 52. Montgomery A. et al. 2016 . Curcumin sensitizes silymarin to exert synergistic anticancer activity in colon cancer cells.

  • Frontiers in Oncology ISSN X

    Frontiers in Oncology publishes articles on the most outstanding discoveries across the entire research spectrum of Oncology. The mission of Frontiers in Oncology is to bring all relevant Specialties in Oncology together on a single platform. Frontiers in Oncology is composed of the following Specialty Sections Frontiers in Cancer Endocrinology.

  • Frontiers in Oncology Head and Neck Cancer

    Scope. This specialty is devoted to the rapid and efficient publication of authoritative articles relevant to head and neck cancer. With the increasing understanding that head and neck cancer is not one but rather several different diseases as highlighted by

  • Frontiers in Quantitative Cancer Modeling Computational

    May 24 2021  Computational and Systems Oncology. First Published 01 March 2021. We integrate transcriptomic analysis with biophysical modeling to investigate the heterogeneity of tumors and circulating tumor cells CTCs across the epithelial mesenchymal transition EMT spectrum. In silico modeling predicts different conditions where CTCs are more

  • New frontiers in oncology biosimilar monoclonal

    Dec 25 2014  Journal Expert Review of Anticancer Therapy Volume 15 2015Issue 3. Submit an article Journal homepage. 887 Views 17 CrossRef citations to date Altmetric Review New frontiers in oncology biosimilar monoclonal antibodies for the treatment of breast cancer. Marc Thill Department of Gynecology and Obstetrics Agaplesion Markus Hospital

  • Journal of Cancer Research and Clinical Oncology Home

    Human umbilical cord mesenchymal stem cells derived exosomal microRNA 181a retards

  • Frontiers in Immunology Aggrego Oncology

    Aggrego Oncology is a digital news aggregator that brings relevant reliable oncology news directly to you based upon your preferences. Journal of oncology pharmacy practice official publication of the International Society of Oncology Pharmacy Practitioners #16ed68. Journal of Ovarian Research.

  • Frontiers Retraction ECT2 Increases the Stability of

    Following publication concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation which was conducted in accordance with Frontiers’ policies.This retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor of Frontiers.

  • Journal informationJournal of Neuro Oncology Home

    Jul 24 2021  The Journal of Neuro Oncology is a multi disciplinary journal encompassing basic applied and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists neurosurgeons radiotherapists medical oncologists neuropathologists neurodiagnosticians and laboratory based

  • Aggrego News Aggrego Oncology

    Jul 14 2021  New research published in the Journal of Thoracic Oncology suggests the method used to calculate how obesity is measured may affect whether it is considered a risk factor for lung cancer. Oncology TimesLatest Articles. 07/20/2021.

  • The association between the expression of nuclear Yes

    May 10 2021  American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Journal of clinical oncology official journal of the American Society of Clinical Oncology. 2010 28 16 2784–95. PMC free article Google Scholar

  • Loop Frontiers in Oncology Editorial Office

    Email oncology.editorial.office frontiersin. Twitter FrontOncology. Description Frontiers in Oncology is an open access journal that aims at publishing the best research across the entire field of oncology. The journal welcomes outstanding contributions in any domain of cancer research from basic laboratory research to clinical

  • Neoadjuvant chemotherapy NACT is an effective way of

    May 30 2012  Gabriele Siesto Raffaele Cavina Fabrizio Romano Domenico Vitobello Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer American Journal of Clinical Oncology 10.1097/COC. 1 2016 .

  • Case Reports in Oncology IJCRI Oncology

    Journal of Case Reports and Images in Oncology is an international peer reviewed open access journal publishing high quality case reports in oncology and related subspecialties. The scope of the journal covers oncology and related disciplines including etiology mechanisms molecular studies tumor therapy general diagnosis laboratory

  • Immuno Oncology Aggrego Oncology

    Mar 01 2021  Defining best practices for tissue procurement in immuno oncology clinical trials consensus statement from the Society for Immunotherapy of Cancer Surgery Committee. Immunotherapy is now a cornerstone for cancer treatment and much attention has been placed on the identification of prognostic and predictive biomarker.

  • Journal Rankings on Oncology

    International Scientific Journal Country Ranking. Only Open Access Journals Only SciELO Journals Only WoS Journals